Nicotinamide Mononucleotide Adenylyltransferase 1 and NAD<sup>+</sup> Homeostasis in Neuroprotection and Aging. [PDF]
Sun Y, Li B, Qian Z.
europepmc +1 more source
SLFN11 expression as a marker of small cell lung cancer vulnerability to combined PARP inhibitors and immune checkpoint inhibitors during maintenance. [PDF]
Pujol JL.
europepmc +1 more source
Chromatin relaxation dynamics and histone PTMs in the early DNA damage response. [PDF]
Qian J, Xie Z, Zhou L, Zhu WG.
europepmc +1 more source
DNA-PKcs and PARP1 at the interface between DNA damage responses and cGAS-STING signaling: context-dependent roles and therapeutic implications. [PDF]
Miao T +5 more
europepmc +1 more source
Molecular Determinants of Response and Rational Drug Combinations for Antibody-Drug Conjugates (ADCs) with Topoisomerase I (TOP1) Inhibitor Payloads. [PDF]
Pommier Y.
europepmc +1 more source
Disrupting the tumor-associated TNKS-USP25 protein-protein interface in cancer: structural basis, druggability, and therapeutic opportunities. [PDF]
Kamel EM +6 more
europepmc +1 more source
Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation. [PDF]
Fan J, Song Y.
europepmc +1 more source
Mapping the Subtype-Specific PARP1 ADP-Ribosylated Proteome in Breast Cancer Cells. [PDF]
Koul S +9 more
europepmc +1 more source
Shuttle and stabilize: H1.2-FUS complex in amyotrophic lateral sclerosis pathogenesis. [PDF]
Petrovic D, Perçin G, Vilchez D.
europepmc +1 more source
A Double-Edged Sword: The Two Faces of PARylation
Poly ADP-ribosylation (PARylation) is a post-translational modification process. Following the discovery of PARP-1, numerous studies have demonstrated the role of PARylation in the DNA damage and repair responses for cellular stress and DNA damage ...
Jun Hong Park +2 more
exaly +2 more sources

